Histogenics Corporation (HSGX) financial statements (2021 and earlier)

Company profile

Business Address 5 GREAT VALLEY PARKWAY
MALVERN, PA 19355
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2471683231
Cash and cash equivalents2471673231
Short-term investments   1  
Prepaid expense  1000
Assets held-for-sale, not part of disposal group 7    
Other current assets  0000
Other undisclosed current assets21 000
Total current assets:26161683231
Noncurrent Assets
Property, plant and equipment100345
Intangible assets, net (including goodwill)     0
Intangible assets, net (excluding goodwill)     0
Restricted cash and investments000000
Other noncurrent assets111   
Total noncurrent assets:111346
TOTAL ASSETS:271717113637
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:343343
Accounts payable02212 
Accrued liabilities32132 
Employee-related liabilities     1
Other undisclosed accounts payable and accrued liabilities     2
Debt00 011
Deferred rent credit  0
Deferred lease income  0
Due to related parties    0 
Deferred revenue and credits010
Other liabilities00    
Other undisclosed current liabilities0    3
Total current liabilities:453456
Noncurrent Liabilities
Long-term debt and lease obligation21  01
Long-term debt, excluding current maturities21  01
Operating lease, liability00
Liabilities, other than long-term debt 01418171
Deferred revenue and credits111
Accounts payable and accrued liabilities  31513 
Contract with customer, liability10
Deferred rent credit  0
Due to related parties  133 
Other liabilities 0    
Other undisclosed noncurrent liabilities(0) 1   
Total noncurrent liabilities:211518172
Total liabilities:661822239
Stockholders' equity
Stockholders' equity attributable to parent, including:2211(0)(11)1428
Common stock211000
Treasury stock, value(0)(0)    
Additional paid in capital9362216197195194
Retained earnings (accumulated deficit)(73)51(217)(208)(182)(166)
Other undisclosed stockholders' equity attributable to parent (103)    
Total stockholders' equity:2211(0)(11)1428
TOTAL LIABILITIES AND EQUITY:271717113637

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Gross profit:0     
Operating expenses(21)(14)(30)(25)(30)(32)
Operating loss:(21)(14)(30)(25)(30)(32)
Nonoperating income (expense)(1)(6)21(1)14(0)
Other nonoperating income (expense)0(1)(0)(0)(0)(0)
Interest and debt expense(1)(2)2 (0)(0)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes  (2)(0)00
Loss before gain (loss) on sale of properties:(23)(22)(9)(26)(16)(32)
Other undisclosed net income12    
Net loss:(22)(20)(9)(26)(16)(32)
Other undisclosed net income attributable to parent   0  
Net loss attributable to parent:(22)(20)(9)(26)(16)(32)
Preferred stock dividends and other adjustments(13)     
Other undisclosed net income available to common stockholders, basic  042 
Net loss available to common stockholders, basic:(34)(20)(9)(22)(14)(32)
Dilutive securities, effect on basic earnings per share  (21)   
Other undisclosed net loss available to common stockholders, diluted    (18) 
Net loss available to common stockholders, diluted:(34)(20)(29)(22)(31)(32)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(22)(20)(9)(26)(16)(32)
Comprehensive loss:(22)(20)(9)(26)(16)(32)
Other undisclosed comprehensive loss, net of tax, attributable to parent (0)    
Comprehensive loss, net of tax, attributable to parent:(22)(20)(9)(26)(16)(32)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: